loadpatents
name:-0.0099689960479736
name:-0.0046288967132568
name:-0.0023682117462158
MELLORS; John W. Patent Filings

MELLORS; John W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MELLORS; John W..The latest application filed is for "integrated proviral sequencing assay".

Company Profile
1.5.8
  • MELLORS; John W. - Pittsburgh PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Integrated Proviral Sequencing Assay
App 20220042120 - JOSEPH; Kevin ;   et al.
2022-02-10
Molecules that bind to SARS-CoV-2
Grant 10,822,379 - Dimitrov , et al. November 3, 2
2020-11-03
3'-azido purine nucleotide prodrugs for treatment of viral infections
Grant 8,815,829 - Schinazi , et al. August 26, 2
2014-08-26
3'-azido Purine Nucleotide Prodrugs For Treatment Of Viral Infections
App 20120135951 - Schinazi, Ph.D.; Raymond F. ;   et al.
2012-05-31
Azido Purine Nucleosides For Treatment Of Viral Infections
App 20100279969 - Schinazi; Raymond F. ;   et al.
2010-11-04
HIV-1 mutations selected for by .beta.-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine
Grant 7,635,690 - Schinazi , et al. December 22, 2
2009-12-22
Method of detecting AZT resistance in HIV
App 20070196902 - Mellors; John W. ;   et al.
2007-08-23
HIV-1 mutations selected for by beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine
App 20070025964 - Schinazi; Raymond F. ;   et al.
2007-02-01
HIV-1 mutations selected for by .beta.-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine
Grant 7,115,584 - Schinazi , et al. October 3, 2
2006-10-03
Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors
App 20050113331 - Prniak, Michael ;   et al.
2005-05-26
HIV-1 mutations selected for by beta-2',3'-didehydro-2',3'-dideoxy-5-fluor- ocytidine
App 20040082552 - Schinazi, Raymond F. ;   et al.
2004-04-29
Treatment of drug-resistant human immunodeficiency virus infection
App 20030207843 - Hostetler, Karl Y. ;   et al.
2003-11-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed